Technical analysis of NeoGenomics, Inc. (NEO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers.
Price Performance
| 1 month | +17.83% |
| 3 months | +76.37% |
| Year-to-date | +66.92% |
| 1 year | +127.73% |
| 3 years | +53.72% |
52-Week Range
| 52-week High | $20.02 |
| 52-week Low | $7.07 |
| Avg Volume (90d) | 2.4M |
Technical Indicators
| SMA 50 | $16.30 |
| SMA 200 | $11.98 |
| Beta | 1.71 |
| 30-day Volatility (annualised) | 44.4% |
| Price vs SMA 50 | +20.4% |
| Price vs SMA 200 | +63.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $9.77 | |
| 2025-11 | $12.10 | +23.8% |
| 2025-12 | $11.76 | -2.8% |
| 2026-01 | $12.06 | +2.6% |
| 2026-02 | $9.83 | -18.5% |
| 2026-03 | $7.42 | -24.5% |
| 2026-04 | $9.26 | +24.8% |
| 2026-05 | $10.52 | +13.6% |
| 2026-06 | $14.59 | +38.7% |
| 2026-07 | $15.29 | +4.8% |
| 2026-08 | $17.91 | +17.1% |
| 2026-09 | $19.63 | +9.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-16 | | |
| 2026-09-16 | $-0.03 | $1M |
| 2026-09-16 | | $352M |
| 2026-09-16 | | $5M |
| 2026-09-16 | | |
| 2026-09-16 | $-55.20 | |
Price
| Price | $19.59 |
| Market Cap | $503M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.66 |
| EV / EBITDA | 58.16 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.57 |
| Current Ratio | 3.60 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 0.53 |